Published: June 2025 | Last updated: May 2026
Human papillomavirus is the most common sexually transmitted infection in the world. The CDC notes that nearly everyone who is not vaccinated will get HPV at some point in their lives, and most will never know it happened. There are no early symptoms, no test offered at a routine checkup if you are under 30, and no visible sign for the great majority of infections.
That silence is the whole problem. HPV does not always cause warts. It does not appear on a standard STI panel. The strains that matter for long-term health, the ones linked to cervical, anal, throat, penile, and vulvar cancers, can sit in tissue for years without changing anything you would feel or see. The good news is that most infections clear on their own. The catch is that you have to know it is there to make any of the decisions that come next.
The Most Common STI You've Probably Never Felt
According to the CDC's HPV about page, more than 42 million Americans are currently infected with HPV strains known to cause disease, and about 13 million Americans (including teens) become newly infected each year. Most new infections show up in teenagers and people in their twenties, often within the first few years of becoming sexually active.
There are more than 200 HPV strains catalogued so far. About 40 of them can infect genital, anal, and oral tissue. A subset of around a dozen are classified as high-risk, meaning they have a meaningful association with cancers of the cervix, vulva, vagina, penis, anus, and oropharynx (the back of the throat). The remaining genital strains are low-risk: they may cause warts, but they do not cause cancer.
Why is this so easy to miss? HPV does not need penetration to spread. Skin-to-skin contact in the genital area is enough. Condoms reduce risk but cannot cover every patch of skin that might be infectious. And because the immune system clears most infections quietly, two partners can pass a strain back and forth across months without either of them feeling a thing.
More than 200 HPV strains have been catalogued. About 40 infect genital, anal, or oral tissue. Roughly a dozen are classified as high-risk for cancer. The rest either cause warts (low-risk) or produce no symptoms at all.
Where HPV Settles Into the Body
The older framing of HPV as strictly a cervical-cancer issue is outdated. The virus favors warm, moist mucosal tissue, and that exists in several places most people do not associate with sexual health.
HPV is documented at three main anatomic sites:
- Throat (oropharyngeal HPV): Usually transmitted through oral sex. The CDC's HPV-associated cancer data page attributes about 70% of oropharyngeal cancers in the U.S. to HPV, and the rate has been climbing fastest in men.
- Anus and rectum: Anal HPV occurs across all sexual orientations, with higher prevalence in receptive anal sex. It is often picked up only when abnormal cell changes appear on an anal cytology test, which most providers do not order routinely.
- Cervix, vagina, and vulva: The longest-studied site. Persistent infection with a high-risk strain is the main driver of cervical cancer, which is why pap smears and HPV DNA tests exist.
Penile HPV is also common in men with a penis, but it progresses to cancer far less often than the other sites. You will not feel HPV enter the body, and you will not see a sign for the great majority of infections. Screening, rather than symptom-watching, is the only reliable way to catch it.
HPV in Men: The Risk No One Routinely Screens For
There is no FDA-approved HPV screening test for men. The CDC does not recommend population-level screening for this group, mainly because no early-detection pathway for men is as well validated as cervical cytology is for women. That clinical absence collides with real-world prevalence in a frustrating way.
A widely cited 2017 JAMA Oncology analysis summarized by the CDC found that nearly 1 in 3 men aged 18 to 59 in the U.S. carries a genital HPV infection at any given time, with about 1 in 5 carrying a high-risk strain. Most of those infections will clear on their own, but a meaningful minority will not, and those are the ones quietly contributing to oropharyngeal and anal cancer rates.
What HPV can lead to in men:
- Genital warts (cosmetic and contagious, but not cancerous)
- Oropharyngeal cancer, the fastest-growing HPV-related cancer in the U.S.
- Penile cancer (rare)
- Anal cancer (rare in cis men generally, higher in men who engage in receptive anal sex, much higher in people with HIV)
The honest framing on at-home testing: there is no validated home test that screens men for HPV reliably. Our HPV at-home rapid swab kit is validated for vaginal self-collection only. Men who want clarity should talk to a clinician about visual examination, anal cytology if the relevant risk factors apply, and HPV vaccination if they are still inside the eligible age range. Vaccination is the single most useful prevention tool currently available for men.
No FDA-approved HPV screening test currently exists for men. Visual examination by a clinician, anal cytology where risk factors apply, and HPV vaccination through age 45 remain the main clinically validated tools.
How HPV Testing Actually Works
“Did you test me for HPV?” is one of the most useful questions you can ask at a gynecology or sexual-health visit. Many providers default to a pap smear alone if you are under 30, and pap smears do not test for HPV itself. They examine cervical cells under a microscope and flag changes that might be precancerous. A sample full of HPV virus can still produce a perfectly normal pap result if cell changes have not started yet.
The three tests you might encounter:
- Pap smear (cytology): Looks at cervical cells. Catches changes that have already started. Recommended every three years from age 21 in most current U.S. guidelines.
- HPV DNA test (lab): Looks for the genetic material of high-risk HPV strains directly. Run on a cervical sample, typically co-tested with a pap smear from age 30 onward (every five years if HPV-negative).
- HPV antigen rapid test (the at-home category): A lateral-flow swab test that screens for HPV antigens at home. Useful for women who want a private first look, or who do not have current access to routine cervical screening. A positive result is a flag to follow up with a clinician for strain typing and a pap smear, not a final diagnosis.
None of these replaces the others. An at-home rapid screen flags a positive result for clinical follow-up. A lab HPV DNA test identifies specific strains. A pap smear or biopsy reads what cells are actually doing. The most thorough picture, when there is a positive screen or a known risk factor, uses several of these together over time.
Disclosure: this site sells at-home rapid test kits. The product below is one of our listings, and we recommend it because it fits the screening question being discussed, not because of placement value.
How do I get tested for HPV?
If you have a cervix: ask your provider for an HPV DNA test (most useful from age 30; available co-tested with a pap smear). For an at-home first look, vaginal self-swab antigen kits can flag a result worth following up with a clinician. There is no FDA-approved HPV screening test for men, so people without a cervix should discuss visual exams, anal cytology where indicated, and HPV vaccination with a clinician. Most home tests are screening tools, not final diagnoses.
The Vaccine Covers a Lot, but Not Everything
Gardasil 9, the only HPV vaccine currently distributed in the U.S., covers nine HPV strains: 6, 11, 16, 18, 31, 33, 45, 52, and 58. Those nine include the two strains responsible for most genital warts (6 and 11) and the seven highest-risk strains for cervical and other HPV-related cancers. According to the CDC's HPV vaccine guidance, this lineup prevents roughly 90% of HPV-related cancers when given before exposure.
The current ACIP recommendations:
- Routine vaccination starting at age 11 to 12 (can be given as early as age 9)
- Catch-up vaccination through age 26 for anyone not adequately vaccinated
- Shared clinical decision-making between ages 27 and 45 (most benefit goes to people with new sexual partners, lapsed coverage, or unknown HPV history)
People who start the Gardasil 9 series before their 15th birthday need two doses; those who start at age 15 or older need three doses spread over six months.
The vaccine works best as primary prevention before exposure, but it is not pointless afterward. You may have already cleared some strains naturally; the vaccine still protects against the others you have not encountered yet. It does not treat an existing infection, and it does not change the cancer trajectory of a strain that is already established.
In 90% of people the body controls the infection by itself. The immune system usually clears HPV from the body within a year or two with no lasting effects.
Putting Cancer Risk in Proper Context
Reading “HPV is linked to cancer” without the math turns a common, usually self-clearing infection into a panic trigger. The math is more reassuring than the headline.
According to the WHO's HPV and cancer fact sheet, about 90% of HPV infections become undetectable within two years thanks to the immune system. Of the small fraction that persist, only some progress to cell changes; of those, only some progress to actual cancer; and that progression typically takes 10 to 20 years.
In plain terms: HPV is common, persistent high-risk HPV is uncommon, and HPV-related cancer is rarer still. The screening tools that exist (pap smears, HPV DNA tests, anal cytology where indicated) are powerful because they catch problems in that long pre-cancer window. Used as designed, they prevent most cancers from ever developing. The takeaway is practical: stay on your screening schedule rather than spiral about a single result.
Two lifestyle factors meaningfully shift the math in the other direction: smoking and immunosuppression. Smoking slows HPV clearance and raises progression risk for cervical and oropharyngeal cancers. People living with HIV have higher rates of persistent infection and a steeper cancer-risk curve, which is why anal cytology screening is part of standard HIV care for many providers.
What to Do If You Test Positive
A positive HPV result is not a diagnosis, a moral judgment, or a transmission accusation. It is a single piece of information that opens a follow-up conversation. What positive actually means depends on which test came back:
- Positive at-home antigen rapid test: Treat as a screening flag, not a final answer. Follow up with a clinician for an HPV DNA test that identifies the specific strain (high-risk vs low-risk) and a pap smear if you have a cervix.
- Positive HPV DNA test, low-risk strain: The strain causes warts but not cancer. If warts are present and bothersome, providers can remove them. The body usually clears the infection over the next one to two years.
- Positive HPV DNA test, high-risk strain, normal pap: The most common pattern. You will be asked to come back for a repeat HPV/pap co-test in 12 months. Most infections clear before then.
- Positive HPV DNA test, abnormal pap: The most actionable scenario. The next step is usually colposcopy, a closer look at the cervix with a magnifying scope, and a small biopsy if anything looks suspicious. Most findings at this stage are still pre-cancer and treatable.
What you can do beyond clinical follow-up: do not smoke, limit alcohol, keep regular sleep and nutrition. Smoking specifically slows HPV clearance and increases the progression risk for cervical and oropharyngeal cancers. If you are not yet vaccinated and are inside the eligible window, talk to a clinician about Gardasil 9 even after a positive result; it still covers the strains you have not encountered.
One more practical note. A positive HPV test does not have a duty-to-disclose status the way HIV does in most jurisdictions. Many people choose to tell partners anyway, particularly with visible warts or a confirmed high-risk strain. Given that most sexually active adults will get HPV at some point, the framing of those conversations is usually less dramatic than the run-up to having them suggests.
Why HPV Care Is Finally a Conversation for Everyone
For a long time, HPV got filed under “cervical cancer screening,” which left out roughly half the population. That is changing. The CDC has been recommending HPV vaccination for boys since 2011, and shared decision-making guidance now applies across genders up to age 45. Anal cytology screening for higher-risk groups (people with HIV, men who have receptive anal sex) is increasingly part of standard care rather than an unusual request.
Public-health bodies now treat HPV screening less as a one-time test and more as a lifetime maintenance question, similar to cholesterol or blood pressure. You check periodically and adjust based on what you find, without panicking about a single result.
At-home screening is filling gaps that the clinic system has not closed:
Common Questions About HPV
- Can HPV show up in the throat?
- Yes. Oral HPV infects the back of the throat (the oropharynx) and is responsible for about 70% of oropharyngeal cancers in the U.S. according to CDC data. It is usually transmitted through oral sex. There is no FDA-approved screening test for oral HPV currently available; clinicians look for visible lesions and any concerning symptoms that persist.
- Does HPV always cause symptoms?
- No. The vast majority of HPV infections cause no symptoms at all, which is why screening rather than symptom-watching is how the virus and its complications get caught early.
- How do you get HPV?
- Through vaginal, anal, or oral sex, and through close skin-to-skin contact in the genital area. Penetration is not required. Condoms reduce risk substantially but do not eliminate it because HPV can spread from skin not covered by the condom.
- Can men get tested for HPV?
- There is no FDA-approved HPV screening test for men. Visual inspection by a clinician can catch warts, and anal cytology may be recommended for higher-risk individuals (people with HIV or those who engage in receptive anal sex). HPV vaccination remains the most useful tool currently available for men.
- Does HPV go away on its own?
- For most people, yes. The immune system clears roughly 9 in 10 infections within two years without any treatment. What matters is the minority that does not clear: persistent high-risk infection is what drives HPV-related cancer risk, which is why follow-up after a positive result is important even when symptoms are absent.
- Should I tell my partner I have HPV?
- HPV disclosure is not legally mandatory in most places, but it builds trust and helps partners make informed decisions, especially if visible warts are present or if a high-risk strain has been confirmed. Given that most sexually active adults will get HPV at some point, the framing of these conversations is often less dramatic than people fear.
- Do condoms prevent HPV?
- They reduce risk significantly but do not eliminate it. HPV lives on skin, and condoms cover only some of the relevant skin area. Condoms paired with HPV vaccination provide the strongest available protection.
- What is the difference between a pap smear and an HPV test?
- A pap smear examines cervical cells under a microscope to look for changes that might be precancerous. An HPV test (HPV DNA test) detects the virus itself. They are often run together as a co-test in people over 30. A pap smear can be normal while an HPV test is positive, and vice versa, which is why the two tests answer different questions.
- U.S. Centers for Disease Control and Prevention. HPV resource hub covering transmission, cancer association, vaccine recommendations, and at-risk groups.
- U.S. Centers for Disease Control and Prevention. HPV about page with current U.S. prevalence figures (42 million infected; 13 million new infections per year) and vaccination context.
- U.S. Centers for Disease Control and Prevention. HPV-associated cancer cases data page covering the 70% oropharyngeal-cancer attribution.
- U.S. Centers for Disease Control and Prevention. Clinical overview of HPV for healthcare providers, including prevalence data in men summarized from the JAMA Oncology analysis.
- World Health Organization. Fact sheet on human papillomavirus and cancer, covering global burden, transmission, clearance rates, and prevention.
- NHS. Human papillomavirus (HPV) overview: symptoms, transmission, and current UK vaccination guidance.
- Mayo Clinic. HPV infection: symptoms, causes, and routine screening overview for patients.
